Vaxira
Monoclonal antibody indicated in treatment of patients with advanced non small cell lung cancer (NSCLC).
Therapeutic Area
Oncology
Active Ingredient
Racotumomab
Line
Oncology
Pharmaceutical Form
1 ampoule bottle with 1 mg solution
